United States · FDA National Drug Code directory
Omlonti
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84826-002_33504c5f-664b-4f6b-e063-6294a90a2aea
- Product NDC
- 84826-002
- Form
- SOLUTION/ DROPS
- Composition / generic term
- omidenepag isopropyl
- Labeler
- Ocuvex Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220923
- Source listing expiry
- 20261231
Source-listed ingredients
- OMIDENEPAG ISOPROPYL — .02 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (84826-002-01) / 2.5 mL in 1 BOTTLE, PLASTIC · 84826-002-01
- 3 BOTTLE, PLASTIC in 1 CARTON (84826-002-03) / 2.5 mL in 1 BOTTLE, PLASTIC · 84826-002-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →